Product Benefits

• Stable Blood Sugar Control: Xil CR 82.5mg contains Gliclazide, which stimulates the pancreas to produce insulin, helping to maintain healthy blood glucose levels in patients with Type 2 Diabetes.

• Controlled Release (CR) Technology: The advanced CR formulation allows for a gradual and steady release of the medication into the bloodstream, preventing sudden spikes or drops in blood sugar.

• Reduced Risk of Hypoglycemia: Compared to older sulfonylureas, the controlled release of Gliclazide is associated with a lower risk of dangerously low blood sugar (hypoglycemia).

• Cardiovascular Protection: Clinical studies suggest that Gliclazide may offer long-term protective benefits for the small blood vessels, reducing the risk of diabetic complications like kidney or eye damage.

• Once-Daily Convenience: The 82.5mg CR strength is often prescribed as a single daily dose (usually with breakfast), improving patient adherence to the treatment plan.

• Weight Neutrality: Unlike some other diabetes medications, Gliclazide is generally considered to have a more favorable profile regarding weight gain.

• Restores Natural Insulin Response: It specifically enhances the first phase of insulin secretion, which is often lost in the early stages of Type 2 Diabetes.

• Trusted Quality: Manufactured by AristoPharma Ltd., ensuring that the medication meets international standards for purity, safety, and effectiveness.